Vimian is a global animal health company covering four essential and rapidly evolving areas: Specialty Pharma, MedTech, Veterinary Services and Diagnostics. At Vimian, we believe that every animal deserves the best available care. We bring pioneering and entrepreneurial businesses together to make the market’s most innovative offerings accessible to more animal health professionals and pet owners. Headquartered in Stockholm, Sweden, Vimian reaches over 17,000 veterinary clinics and laboratories, sells to over 80 markets, has 1,200 employees and annual revenues of approximately EUR 375 million. For more information, please visit: www.vimian.com.
| Website | http://www.vimian.com |
| Revenue | $161.5 million |
| Employees | 27 (20 on RocketReach) |
| Founded | 2021 |
| Phone | +1 301-816-2424 |
| Industry | Veterinary Services |
| Keywords | Animal Health, Scientific Innovation, Health Solutions, Veterinary Medicine, Technological Advancement, Biotechnology Solutions, Animal Pharmaceuticals, Global Solutions, Innovative Solutions, Livestock Health, Customer-Centric Approach, Animal Diagnostics, Animal Care, Sustainable Practices, Pet Health, Animal Welfare, Animal Nutrition, Agricultural Technology, Animal Biotechnology, Precision Livestock Farming |
| Competitors | Merck Animal Health, Pfizer, Zoetis, IDEXX, Elanco, Hill's Pet Nutrition, Neogen Corporation, Vetoquinol Global, Merial S.A.S., Foresight Science & Technology +35 more (view full list) |
Looking for a particular Vimian Group employee's phone or email?
The Vimian Group annual revenue was $161.5 million in 2026.
Alireza Tajbakhsh is the CEO of Vimian Group.
20 people are employed at Vimian Group.
Vimian Group is based in Stockholm, Stockholm County.